Brief: Fibrobiologics Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
25/11/2025 22:34
Nov 25 (Reuters) - Fibrobiologics Inc FBLG.O: FIBROBIOLOGICS ANNOUNCES CLOSING OF $1.5 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES Source text: ID:nGNX8q6zdj Further company coverage: FBLG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fibrobiologics
See all newsBrief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body
Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts